Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rhabdomyosarcoma, Alveolar × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 5 Neuroblastoma 3 Lymphoma 3 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Large-Cell, Anaplastic 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

temsirolimus 1 ganitumab 1 efineptakin alfa 1 Vinorelbine 1 Vincristine 1 Sirolimus 1 Receptor Protein-Tyrosine Kinases 1 Radiotherapy 1 Radiation 1 Irinotecan 1 Dasatinib 1 Dactinomycin 1 Cyclophosphamide 1 BAY 1895344 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡